Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

89Zr-DFO-Atezolizumab ImmunoPET/CT in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04006522
Recruitment Status : Recruiting
First Posted : July 5, 2019
Last Update Posted : August 4, 2022
Information provided by (Responsible Party):
James Brugarolas, University of Texas Southwestern Medical Center

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : July 15, 2024
Estimated Study Completion Date : July 15, 2025